Adrian Gottschalk - Sep 16, 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Executive Officer, Director
Signature: /s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Stock symbol: FHTX
Transactions as of: Sep 16, 2022
Transactions value $: $21,600
Form type: 4
Date filed: 9/19/2022, 04:06 PM
Previous filing: Feb 22, 2023
Next filing: Jan 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Options Exercise	$21.6K	+40K	+27.31%	$0.54^*	186K	Sep 16, 2022	Direct
holding	FHTX	Common Stock						325K	Sep 16, 2022	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Option (right to buy)	Options Exercise	$0	-40K	-8.72%	$0.00	419K	Sep 16, 2022	Common Stock	40K	$0.54	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 25,225 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F2	The option vested as to 25% of the underlying shares of common stock on May 30, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested.